Epstein--Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes
Authors:
- G. SauvageauGSG. Sauvageau
- R. StoccoRSR. Stocco
- S. KasparianSKS. Kasparian
- J. MenezesJMJ. Menezes
- 1 February 1990
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 71 (2) , 379-386
Abstract
In 1977 we showed that cells of a human lymphocytic leukaemia-derived T line (Molt-4) have receptors for Epstein-Barr virus (EBV). More recently, EBV-positive human T cell lymphomas have been recognized and human T cell lines containing the EBV genome have been established in vitro. To understand better the interaction of EBV with T cells, we decided to determine first whether human peripheral blood T lymphocytes express receptors for EBV. Using flow cytometry we examined the binding of both lymphocyte-transforming (B95-8) and non-transforming (P3HR-1) strains of EBV to T lymphocyte subpopulations, using a double labelling technique with T cell-specific phycoerythrinated monoclonal antibodies (Leu 2a) and fluoresceinated viral preparation. Our results suggest that, in general, about 50% of the CD8+ (or suppressor/cytotoxic) T cell subpopulation from both EBV-seropositive and -seronegative individuals can bind EBV. EBV receptor expression on these T cells was about 10 and 51 times less than that on Molt-4 and Raji (an EBV receptor-positive B cell line) cells, respectively. The specificity of this binding was demonstrated by the inhibition of attachment of viral preparations preincubated with a monoclonal antibody directed against the viral ligand (gp240/350), and by preincubating these target T cells with unlabelled virus. We were unable to detect EBV-induced antigens in infected T cells, suggesting that, as in Molt-4 cells, virus internalization may not occur in fresh T cells and/or that the virus receptor may not be completely functional. We were also unable to detect C3d (or CR2) receptors on these T cells, or to inhibit virus attachment by treating the targets with an anti-CR2 monoclonal antibody (OKB7), suggesting that the EBV receptor on CD8+ peripheral blood lymphocytes is different from that on B cells.Keywords
This publication has 29 references indexed in Scilit:
- EPSTEIN-BARR VIRUS IN A MALIGNANT LYMPHOPROLIFERATIVE DISORDER OF B-CELLS OCCURRING AFTER THYMIC EPITHELIAL TRANSPLANTATION FOR COMBINED IMMUNODEFICIENCY1981
- Deficiency of Epstein-Barr virus (EBV) receptors on B lymphocytes from certain patients with common varied agammaglobulinemia.The Journal of Immunology, 1980
- Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective studyNature, 1978
- Identification of the target cells in human B lymphocytes for transformation by epstein-barr virusVirology, 1977
- Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4)Journal of Virology, 1977
- Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell linesInternational Journal of Cancer, 1976
- Surface Markers on Human B and T LymphocytesScandinavian Journal of Immunology, 1976
- Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformationInfection and Immunity, 1976
- Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.Proceedings of the National Academy of Sciences, 1968
- Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt CellsScience, 1967